Knowledge and Proportion of COVID-19 Vaccination and Associated Factors Among Cancer Patients Attending Public Hospitals of Addis Ababa, Ethiopia, 2021: A Multicenter Study

Fitalew Tadele Admasu Department of Biomedical Sciences, College of Health Sciences, Debre Tabor University, Debre Tabor, EthiopiaCorrespondence: Fitalew Tadele AdmasuDepartment of Biomedical Sciences, College of Health Sciences, Debre Tabor University, PO Box: 272, Debre Tabor, EthiopiaTel +251 918...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Tadele Admasu F
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2021
Materias:
Acceso en línea:https://doaj.org/article/7c6678f1d9f64c65b30e6122d65f01a5
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
Descripción
Sumario:Fitalew Tadele Admasu Department of Biomedical Sciences, College of Health Sciences, Debre Tabor University, Debre Tabor, EthiopiaCorrespondence: Fitalew Tadele AdmasuDepartment of Biomedical Sciences, College of Health Sciences, Debre Tabor University, PO Box: 272, Debre Tabor, EthiopiaTel +251 918290166Email fitalewtadele@gmail.comBackground: Cancer patients are classified as being at high risk of contracting COVID-19 infection, hospitalization, and death and were recommended to have early access to the limited COVID-19 vaccine. However, there are limited studies on the knowledge and acceptance of the COVID-19 vaccine among cancer patients. Therefore, this study aimed at assessing the awareness, readiness, and associated factors among cancer patients.Methods: Institution-based cross-sectional study was conducted on 422 cancer patients from May to August, 2021. A structured interviewer-administered questionnaire was used to collect primary data. A systematic random sampling technique was used to select study participants. Descriptive statistics and binary logistic regression followed by multivariable analysis were performed to investigate the independent association of factors with the outcome variable. Finally, statistical significance was declared at P < 0.05 using AOR and 95% CI.Results: From the 422 cancer patients who participated, 77 (18.2%) had a history of COVID-19 infection, and 224 (55%) believe that the cancer disease will not make them more vulnerable to be infected by COVID-19. Accordingly, younger age (18– 30 years) (AOR = 2.73: 95% CI: 0.18, 4.51), female (AOR = 6.4: 95% CI: 0.7, 13.8), having information about COVID-19 vaccine (AOR = 6.9: 95% CI: 3.1, 15.2), COVID-19 infection history (AOR = 6.0: 95% CI: 2.5, 11.8), duration since cancer diagnosis (≥ 10 years) (AOR= 6.2: 95% CI: 2.6, 14.7), and belief about the likelihood of dying of COVID-19 infection (AOR = 3.05: 95% CI: 1.03, 4.05) were the independent predictors of the likelihood of receiving COVID-19 vaccine among cancer patients.Conclusion: This study has found significant cancer patients with poor knowledge about the vaccine, and the percentage of both the first and second round of COVID-19 vaccination was small. Therefore, information communication with cancer patients and oncologists about the COVID-19 vaccine may help to decrease vaccine hesitancy.Keywords: COVID-19, vaccine, willingness, cancer, Ethiopia